Sign in

Medicines for Malaria Venture (MMV)

@mmv.org
329 followers 197 following 355 posts

A leading global health partnership working to reduce the burden of malaria. We discover, develop and deliver new antimalarial medicines.

PostsRepliesMedia
Medicines for Malaria Venture (MMV) @mmv.org · 6h
PNG shoulders a disproportionate share of the Indo-Pacific's #malaria burden. Closing the gap means understanding why progress is harder in some settings vs others. In PNG, MMV met with partners & communities to explore the strategies and tools needed to accelerate elimination.
000
Medicines for Malaria Venture (MMV) @mmv.org · 24/09/2026
The Malaria Science Index shows how investment in #malaria R&D strengthens global health security and delivers #innovation beyond malaria. It also shows how UK science benefits from international collaboration. Sustained investment is key to elimination: bit.ly/47iA8HC
000
Medicines for Malaria Venture (MMV) @mmv.org · 24/09/2026
Each breakthrough in global health starts with a partnership. The UK is committing more than £100m to product development partnerships (PDPs). For #malaria, sustained investment in PDPs like MMV can help make the next breakthroughs possible. Read more: bit.ly/4he33kP
bit.ly
UK commits more than £100m from aid budget to cutting-edge health research
Exclusive: ‘We’re continuing the UK’s proud track record of supporting science that saves lives,’ development minister Kirsty McNeill tells The Independent
010
Medicines for Malaria Venture (MMV) @mmv.org · 24/09/2026
One dose to cure #malaria. That's the ambition behind WANECAM3, an Africa-Europe consortium developing new tools to change how we fight the disease. Prof. Abdoulaye Djimdé & his team in Mali are providing the scientific leadership to help make it happen: bit.ly/4cS0Dag
000
Medicines for Malaria Venture (MMV) @mmv.org · 22/09/2026
What will it take to end #malaria? New tools that can simplify care. Single-dose cures and long-acting prevention could become elimination accelerators, taking us closer to the finish line. Sustained investment can help get them there.
000
Medicines for Malaria Venture (MMV) @mmv.org · 17/09/2026
#ClimateChange is no longer simply a future threat, but a reality we need to manage and adapt to. For #malaria, building resilience is critical. This means developing simpler medicines that are easier to deliver and use, while strengthening health systems and supply chains.
020
Medicines for Malaria Venture (MMV) @mmv.org · 16/09/2026
#Malaria treatment and prevention needs vary by patient, context and setting. A new review explores how #innovation must respond, from simplifying treatment and providing longer-lasting protection to staying ahead of drug resistance. Read more: bit.ly/46m7KUO
000
Medicines for Malaria Venture (MMV) @mmv.org · 15/09/2026
Different patients need medicines designed for their particular needs. Coartem® Baby, the first antimalarial developed for newborns and young infants weighing 2–5 kg, is now included in the WHO Guidelines for #malaria, supporting broader access. Read more: bit.ly/4iqa5Fr
bit.ly
WHO Guidelines for malaria now include Coartem® Baby for newborns and young infants | Medicines for Malaria Venture
001
Medicines for Malaria Venture (MMV) @mmv.org · 14/09/2026
Does your organization have insights into how AI can improve clinical trial design and documentation? MMV, @dndi.org and @gardp.bsky.social are mapping AI solutions for clinical study design, operations and medical writing. Submission deadline: 7 October Learn more: bit.ly/3UMwkeW
022
Medicines for Malaria Venture (MMV) @mmv.org · 11/09/2026
Women should be protected through research, not from it. Healthcare decisions need evidence, but pregnant & breastfeeding women have historically been excluded from clinical research, leaving critical data gaps. Read our recommendations for ICH E21: bit.ly/3SKgP6C
011
Medicines for Malaria Venture (MMV) @mmv.org · 08/09/2026
#Malaria prevalence in Nigeria among children aged 6–59 months has declined by nearly 64% over the past 15 years. Sustained investment in prevention tools like SMC, treatment, surveillance and public awareness has helped drive this progress. Learn more: bit.ly/4qAN44B
020
Medicines for Malaria Venture (MMV) @mmv.org · 04/09/2026
MMV expresses profound sadness at the news of Vasee Moorthy’s untimely passing – we have lost an exceptional champion of global health. We will miss him sorely and send our deepest condolences to his myriad friends and his beloved family.
000
Medicines for Malaria Venture (MMV) @mmv.org · 02/09/2026
MMV has launched a request for information to identify organizations based in or operating in malaria-endemic countries for a new request for information on #malaria market intelligence and evidence generation. Deadline: 14 October Learn more: bit.ly/4cbgujY
011
Medicines for Malaria Venture (MMV) @mmv.org · 01/09/2026
The Africa–Europe WANECAM3 consortium has launched to advance next-generation #malaria treatments. Through Phase 2 & 3 trials, it aims to advance a single-dose cure to simplify treatment, improve adherence & address antimalarial drug resistance. Read more bit.ly/4x1j0kk
bit.ly
Africa-Europe research partnership launches to advance next-generation single-dose malaria treatments | Medicines for Malaria Venture
021
Medicines for Malaria Venture (MMV) @mmv.org · 31/08/2026
Scientists in Tanzania are seeing early warning signs of antimalarial drug resistance spreading geographically. Molecular surveillance helps countries track how resistance is evolving & make timely #malaria treatment decisions to stay ahead of the threat: bit.ly/4zJou5R
bit.ly
Scientists Warn Drug-Resistant Malaria Mutation Is Spreading Across Lake Victoria Basin - Health Policy Watch
For families here, the rains bring more than greener fields. They also mark the return of malaria.
000
Medicines for Malaria Venture (MMV) @mmv.org · 29/08/2026
From discovery to delivery, collaboration underpins progress against #malaria. This summer in Tokyo, MMV, the GHIT Fund and @gatesfoundation.bsky.social brought together partners from Japan and around the world to strengthen connections and discuss the future of malaria R&D: bit.ly/3UcIUnz
000
Medicines for Malaria Venture (MMV) @mmv.org · 28/08/2026
Encouraging Phase 2 results are supporting further development of a potential new #malaria treatment and prevention combination, which makes use of a promising new compound co-discovered by @ddu-dundee.bsky.social and MMV. Learn more: bit.ly/4gpdanQ
010
Medicines for Malaria Venture (MMV) @mmv.org · 20/08/2026
Global health challenges require global collaboration. This #WorldMosquitoDay, as MMV's flag flies over Geneva, we're celebrating the city's role as a meeting point where partnerships connect expertise and #innovation with communities around the world. 🦟🌍
000
Medicines for Malaria Venture (MMV) @mmv.org · 20/08/2026
#WorldMosquitoDay reminds us that the fight against #malaria is an ongoing challenge, with resistance threatening the tools we rely on. Martin Fitchet & Michael Adekunle Charles call for investment in today's tools AND innovations to stay ahead of resistance bit.ly/4zsl6fc
bit.ly
We cannot afford to lose the fight against drug-resistant malaria | Medicines for Malaria Venture
Every year, World Mosquito Day brings renewed attention to mosquito-borne diseases like malaria. But attention is not enough. What matters now is whether we are using the tools we have effectively and whether those tools will still work tomorrow.
021
Medicines for Malaria Venture (MMV) @mmv.org · 20/08/2026
Building bridges is what we do. For 25+ years, MMV has connected people, expertise and resources around the world. Different bridges, one destination: a #malaria-free future. A fitting spot for our #WorldMosquitoDay group shot!
020
Medicines for Malaria Venture (MMV) @mmv.org · 17/08/2026
#Malaria exploits disruption. A new @malariaconsortium.bsky.social study explores the challenges of delivering SMC in conflict- and flood-affected South Sudan, with lessons other complex settings can benefit from. Read more: bit.ly/4gsQByo
010
Medicines for Malaria Venture (MMV) @mmv.org · 14/08/2026
📢 Call for applications! @afro.who.int & TDR are supporting locally driven implementation research to strengthen health research capacity and generate evidence for countries. Applications: EN, FR & PT Deadline: 15 Sept 2026 Apply: bit.ly/4q9lV8A
020
Medicines for Malaria Venture (MMV) @mmv.org · 13/08/2026
What can a century of #malaria surveillance reveal about the impact of #ClimateChange in Africa? A study in @nature.com finds its impact on childhood malaria varies considerably across the continent, with new risks emerging in East & Southern Africa. More: bit.ly/4g0Yhyh
000
Medicines for Malaria Venture (MMV) @mmv.org · 12/08/2026
#Malaria prevention saves lives. It can also be an investment in children's education & future productivity. A new study suggests expanding SMC to school-aged children could deliver billions in health & economic benefits. More: bit.ly/4fDHBVu
010
Medicines for Malaria Venture (MMV) @mmv.org · 07/08/2026
Pregnant & breastfeeding women must be protected through clinical research, not from it. MMV & partners are calling for actionable guidance to support their inclusion in clinical research and generate robust evidence: bit.ly/4wLXBwa #WorldBreastfeedingWeek
000
Medicines for Malaria Venture (MMV) @mmv.org · 05/08/2026
Relapsing #malaria can cause repeated episodes of illness from a single mosquito bite. A new study from Papua New Guinea & Indonesia is helping build the evidence needed to introduce improved approaches into routine care. More: bit.ly/4fwLLOV
000
Medicines for Malaria Venture (MMV) @mmv.org · 04/08/2026
The cost of responding to antimalarial drug resistance in Africa will only grow as resistance spreads. Beyond new #malaria medicines, investment must also target surveillance, health systems and local manufacturing. More: bit.ly/4pP8Ilm
bit.ly
When Will Malaria Meds Stop Working In Africa?
“The continent should take the matter of resistance very, very seriously...Resistance should be seen as an emergency situation.”
012
Medicines for Malaria Venture (MMV) @mmv.org · 30/07/2026
Congrats to MMV's André-Marie Tchouatieu, who was recognized for his visionary leadership in the fight against #malaria at Benin's La Nuit du Paludisme. The Exceptional Commitment Award celebrates his success in mobilizing minds, inspiring generations and saving countless lives.
010
Medicines for Malaria Venture (MMV) @mmv.org · 29/07/2026
Between 2019 and 2024, Ghana reduced #malaria deaths among children under 5 by 86%. Its experience shows the value of layering interventions and ensuring vaccines, bed nets, diagnosis, treatment and community-centred delivery work together. Read more: bit.ly/4fRxcH6
bit.ly
How Ghana Slashed Child Malaria Deaths By 86% - Health Policy Watch
For decades, malaria has been one of Africa's most persistent health challenges. In Ghana, it was once the leading cause of death for children under five. Bed
000
Medicines for Malaria Venture (MMV) @mmv.org · 23/07/2026
MMV met with leaders from the Japan Institute for Health Security (JIHS) to discuss Japan's approach to #malaria and health security, showcase MMV's pipeline of innovative malaria medicines and explore opportunities for future collaboration.
000
Medicines for Malaria Venture (MMV) @mmv.org · 22/07/2026
Long-acting injectables could provide protection from malaria for up to 6 months with a single administration. Cristina Donini explains how it works. Reaching zero #malaria requires continued #innovation & sustained commitment to get breakthroughs to those who need them most.
000
Medicines for Malaria Venture (MMV) @mmv.org · 21/07/2026
Spotlight on Japan: today, partners from around the world convened in Tokyo for the Japan symposium on #malaria R&D. Discussions focused on the partnerships, science & innovation advancing next-generation malaria prevention & treatment tools. More: bit.ly/4pucJLR
bit.ly
Japan convenes global leaders in malaria research and development to strengthen partnerships for innovative prevention and treatment tools | Medicines for Malaria Venture
000
Medicines for Malaria Venture (MMV) @mmv.org · 21/07/2026
From discovery to delivery, collaboration across the global malaria community underpins innovation and progress. Here are three ways Japan contributes to the fight against one of the world's deadliest diseases.
001
Medicines for Malaria Venture (MMV) @mmv.org · 15/07/2026
#PressRelease A potential new antimalarial has shown promising results in its first study in humans. The investigational non-artemisinin medicine rapidly killed #malaria parasites and was generally well tolerated in infected volunteers. Read more: bit.ly/3T5KJ4Y
bit.ly
New malaria drug candidate shows early promise in human study | Medicines for Malaria Venture
001
Medicines for Malaria Venture (MMV) @mmv.org · 14/07/2026
A single-dose cure for #malaria: one patient, one visit, one treatment, done. MMV’s Cristina Donini explains how it works. Reaching zero malaria requires continued #innovation and the sustained commitment to get the latest breakthroughs to the people who need them most.
000
Medicines for Malaria Venture (MMV) @mmv.org · 13/07/2026
Last week, representatives from the MMV/DNDi joint regulatory sciences platform and medical affairs met with the Ghana FDA at the Ghanaian Mission in Geneva to discuss how we can reinforce our shared commitment to closer regulatory collaboration.
000
Medicines for Malaria Venture (MMV) @mmv.org · 10/07/2026
MMV convened experts in clinical trials, immunology, modelling  & machine learning to define the data needed to build AI-powered models of the immune response to #malaria. Learn more about 3 of our latest AI drug discovery and development partnerships: bit.ly/4yalrCN
000
Medicines for Malaria Venture (MMV) @mmv.org · 09/07/2026
MMV and @deepmirror.bsky.social are advancing the next phase of Drug Design for Global Health (dd4gh), our open-access AI-powered drug discovery platform, with a new grant from the @gatesfoundation.bsky.social. Learn more: bit.ly/4beUFze
bit.ly
MMV and deepmirror continue partnership to advance AI tool for global health drug discovery | Medicines for Malaria Venture
012
Medicines for Malaria Venture (MMV) @mmv.org · 08/07/2026
Have you heard about the new collaboration between MMV, @dndi.org and @gardp.bsky.social? This strategic agreement responds to a growing reality: global health challenges are too complex for any one organization to solve alone. See how collaboration can maximize impact: bit.ly/3SHIzIo
bit.ly
‘It’s possible to have a collective success’: three Geneva health non-profits bolster ties amid shrinking aid - Geneva Solutions
Three Geneva-based health organisations will join forces to speed up research and development into treatments for malaria, neglected diseases and drug-resistant infections, amid global aid cuts and ca...
010
Medicines for Malaria Venture (MMV) @mmv.org · 07/07/2026
From single-dose cures to long-acting injectables, next-gen #malaria tools could transform how the disease is prevented & treated. Today, MMV's Cristina Donini features in the Daily Express, photographed by Rankin for @malarianomoreuk.bsky.social's #FacesOfInnovation campaign: bit.ly/4woWi5v
001
Medicines for Malaria Venture (MMV) @mmv.org · 29/06/2026
EU ability to prevent, detect and respond to infectious diseases relies on global collaboration and thriving #innovation. In this joint paper with PDP partners, we highlight @globalhealthedctp3.bsky.social's role in Europe–Africa research, clinical development and access: bit.ly/4xKn21U
141
Medicines for Malaria Venture (MMV) @mmv.org · 26/06/2026
LAIs are a new frontier in global health. Realizing their potential requires sustained investment and collaboration. MMV's Cristina Donini joined leaders from Gilead Sciences and Johnson & Johnson to discuss how lessons from HIV can advance LAIs for TB and #malaria. bit.ly/3QrqdLj
bit.ly
Long-Acting Injectables: The New Frontier in Global Health
Long-Acting Injectables: The New Frontier in Global Health - Grand Challenges Annual Meeting 2026
000
Medicines for Malaria Venture (MMV) @mmv.org · 23/06/2026
We are deeply saddened by the passing of Prof. Bob Sinden, a dear friend, collaborator and internationally recognized leader in cellular parasitology. We extend our heartfelt condolences to his family, friends and colleagues. Read our tribute: bit.ly/4gASCci
bit.ly
Remembering Professor Robert Sinden, a pioneer in malaria transmission biology | Medicines for Malaria Venture
000
Medicines for Malaria Venture (MMV) @mmv.org · 19/06/2026
We cannot meet today’s health needs with yesterday’s tools. Improving coordination & delivery while neglecting #innovation risks creating a system that is better organized but not more effective. Leaders from MMV, @dndi.org & @gardp.bsky.social explain why: bit.ly/4oyhtzo
bit.ly
Opinion: Global health reform must bolster Innovation | Medicines for Malaria Venture
032
Medicines for Malaria Venture (MMV) @mmv.org · 17/06/2026
MMV and @dndi.org have launched the first joint regulatory sciences platform between PDPs! By bringing together regulatory expertise, we can: → Pool knowledge and speak with one voice → Define evidence standards for future medicines → Strengthen impact Read more: bit.ly/4a4OEEP
bit.ly
MMV and DNDi pool regulatory expertise to accelerate access to lifesaving medicines | Medicines for Malaria Venture
012
Medicines for Malaria Venture (MMV) @mmv.org · 16/06/2026
A new version of #MMVSola is now live 🔹 Dose prediction tools for LAIs 🔹 Enhanced interactive plots & tables 🔹 Improved models to better estimate drug properties 🔹 Built-in documentation & user guides Try it for free here: mmvsola.org
001
Medicines for Malaria Venture (MMV) @mmv.org · 15/06/2026
The antimalarial toolbox we have today was built through partnership. The next generation of interventions will be too. PDPs like MMV bring together the expertise needed to turn scientific discovery into new tools. See why the PDP model matters: bit.ly/4xbMPQq
bit.ly
Medicines for Malaria Venture : Ending Malaria, Rewriting the Future | Healthcare Outlook
Medicines for Malaria Venture is continuing to innovate its R&D pipeline, collaborate with stakeholders, and refine its product development partnership model. Dr Martin Fitchet, CEO, tells us more.
000
Medicines for Malaria Venture (MMV) @mmv.org · 11/06/2026
To accelerate #malaria elimination, next-gen antimalarials must be developed with simplicity in mind. LAIs could provide lasting protection from a single intervention. MMV & partners recently explored how this innovation can support high-burden settings: bit.ly/4wSkvCB
bit.ly
MMV hosts workshop to advance long‑acting injectables for high‑burden diseases | Medicines for Malaria Venture
000
Medicines for Malaria Venture (MMV) @mmv.org · 08/06/2026
"The science has never looked so good or so promising." The challenge is turning scientific progress into medicines that reach the people who need them. Watch MMV's Emma Hannay on the importance of collaboration between @dndi.org, @gardp.bsky.social and MMV.
010
Medicines for Malaria Venture (MMV) @mmv.org · 08/06/2026
#PressRelease @dndi.org, @gardp.bsky.social and MMV are joining forces to strengthen collaboration, maximize the impact of global health R&D, and accelerate the development of life-saving treatments. Read the press release: bit.ly/4fo8xu0
bit.ly
DNDi, GARDP, and MMV join forces to accelerate drug development for patients in greatest need | Medicines for Malaria Venture
021